NCT01357265 Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE2
NCT01356342 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old Status COMPLETED Phase PHASE4
NCT01356316 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE4
NCT01355172 Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old Status COMPLETED Phase PHASE4
NCT01342796 Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects Status COMPLETED Phase PHASE2
NCT01336166 The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine Status COMPLETED Phase PHASE2
NCT01332578 A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies Status COMPLETED Phase PHASE4
NCT01323946 Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children Status COMPLETED Phase PHASE2
NCT01320696 Reverse Genetic H9N2 Influenza Vaccine Study in Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01318876 Surveillance for Adverse Events Following Influenza Immunization Status COMPLETED Phase N/A
NCT01313962 Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01310413 Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age Status COMPLETED Phase PHASE3
NCT01310400 Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children Status COMPLETED Phase PHASE3
NCT01309568 "Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study" Status COMPLETED Phase N/A
NCT01306682 Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity Status COMPLETED Phase PHASE2/PHASE3
NCT01306305 A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere Status COMPLETED Phase PHASE4